نتایج جستجو برای: 52 high week

تعداد نتایج: 2230247  

2013
Jeffrey Shaman Alicia Karspeck Marc Lipsitch

This document is another installment in a series of near real-time weekly influenza forecasts made during the 2012-2013 influenza season. Here we present some of the results of forecasts initiated following assimilation of observations for Week 52 (i.e. the forecast begins December 30, 2012) for municipalities in the United States. The forecasts were made on January 4, 2013. Results from foreca...

Journal: :The New England journal of medicine 2014
Dirk J Blom Tomas Hala Michael Bolognese Michael J Lillestol Phillip D Toth Lesley Burgess Richard Ceska Eli Roth Michael J Koren Christie M Ballantyne Maria Laura Monsalvo Kate Tsirtsonis Jae B Kim Rob Scott Scott M Wasserman Evan A Stein

BACKGROUND Evolocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) cholesterol levels in phase 2 studies. We conducted a phase 3 trial to evaluate the safety and efficacy of 52 weeks of treatment with evolocumab. METHODS We stratified patients with hyperlipidemia according to the risk categories...

2013
J P H Wilding G Charpentier P Hollander G González-Gálvez C Mathieu F Vercruysse K Usiskin G Law S Black W Canovatchel G Meininger

AIMS Canagliflozin is a sodium glucose co-transporter 2 inhibitor developed for the treatment of type 2 diabetes mellitus (T2DM). This randomised, double-blind, placebo-controlled, Phase 3 study evaluated the efficacy and safety of canagliflozin as an add-on to metformin plus sulphonylurea in patients with T2DM. METHODS Patients (N = 469) received canagliflozin 100 or 300 mg or placebo once d...

پایان نامه :0 1374

the following question poped up: is there any relationship between iranian high school efl learners reading comprehension and listening comprehension? then the following null hypothesis (ho) was developed to the test the above, mentioned question. "there is no relationship between high school efl learners reading comprehension and listening comprehension. for nearly 16 weeks, the experimental g...

Journal: :Journal of Crohn's and Colitis 2023

Abstract Background Etrasimod is an investigational, once-daily, oral, selective sphingosine 1-phosphate receptor 1,4,5 (S1P1,4,5) modulator in development for the treatment of ulcerative colitis (UC). The ELEVATE UC 52 trial utilized a treat-through design which evaluated efficacy at week among all subjects randomised from baseline. Here, we report post hoc analysis who did or not achieve clin...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید